drugset / Trial / NCT05017454

Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids

NCT05017454

Phase 0 Completed 67 enrolled Kasr El Aini Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

the aim of this study is to assess the efficacy and safety of sodium valproate-loaded nanospanlastic in the treatment of patchy AA, in comparison to conventional therapy with topical steroids

Timeline

Start
2021-05-01
Primary completion
2023-01-01
Completion
2023-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mometasone furoate Other / unclassified Topical
Subject Valproate Small molecule Topical

Indications